GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $77,000 | -39.8% | 629 | -57.5% | 0.00% | -50.0% |
Q1 2020 | $128,000 | -23.8% | 1,480 | -7.7% | 0.00% | 0.0% |
Q4 2019 | $168,000 | -4.5% | 1,604 | +4.5% | 0.00% | -33.3% |
Q3 2019 | $176,000 | -21.8% | 1,535 | +17.6% | 0.00% | 0.0% |
Q2 2019 | $225,000 | +2.3% | 1,305 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $220,000 | +193.3% | 1,305 | +69.5% | 0.00% | +300.0% |
Q4 2018 | $75,000 | -40.9% | 770 | +4.8% | 0.00% | -50.0% |
Q3 2018 | $127,000 | +122.8% | 735 | +79.3% | 0.00% | +100.0% |
Q2 2018 | $57,000 | – | 410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |